Targeted at-home fertility Proov offers at-home fertility and menopause diagnostics with a science-backed app, presenting an opportunity to upsell enhanced test kits, subscription models, and data-driven coaching services to customers seeking convenient, private wellness solutions.

PdG expertise edge As a leader in tracking pregnanediol glucuronide (PdG) for ovulation insights, Proov can cross-sell to clinics and insurers focusing on hormone health, fertility planning, and personalized treatment strategies, expanding partnerships beyond direct-to-consumer.

Expanded product suite Recent launches such as Empower perimenopause testing, PdG-test, and Path to Pregnancy indicate opportunities to cross-sell to existing users with bundled fertility, perimenopause, and pregnancy testing programs, as well as add-on diagnostics.

Strategic partnerships Collaborations like Hellowisp and HITLAB recognition suggest potential for co-marketing, data-sharing initiatives, and bundled offerings with fertility clinics, telemedicine platforms, and women's health networks.

Funding and growth VC backing and rising revenue indicate readiness for channel expansion, enterprise licensing, and white-label solutions to clinics and employers seeking proactive women's health monitoring and wellness programs.